SCHEMBL21090809

SCHEMBL21090809

CNS(=O)(=O)c1ccc(Br)cc1N

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
LMNA P02545 2/20 0.41
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
GLA P06280 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
HTR6 P50406 1/20 0.36
NMT1 P30419 1/20 0.36
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
CCR2 P41597 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2372357 0.79 CA1 (0.58) MAPTLMNACA1CA2L3MBTL1
SCHEMBL11308756 0.79 SLC40A1 (0.49) MAPTLMNACA1L3MBTL1SMN1; SMN2
SCHEMBL2649761 0.79 L3MBTL1 (0.47) MAPTCA1CA2L3MBTL1GLA
SCHEMBL2371748 0.78 NMT1 (0.56) MAPTLMNACA1CA2NMT1
SCHEMBL1512014 0.76 SLC6A9 (0.44) MAPTLMNACA1CA2L3MBTL1
SCHEMBL5307516 0.76 CA2 (0.50) CA1CA2GLACA7CA9
SCHEMBL30714245 0.76 CA2 (0.50) CA1CA2GLACA7CA9
SCHEMBL264514 0.76 LMNA (0.65) MAPTLMNACA1CA2GLA
SCHEMBL2443419 0.75 CCR2 (0.41) MAPTLMNACA1CA2L3MBTL1
SCHEMBL31370992 0.75 CA1 (0.47) MAPTLMNACA1CA2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019112719-A1 HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS ANGEX PHARMACEUTICAL, INC. (US) 2019-06-13 WO disclosed